In their investigation, they isolated populations of epithelial (Epcam+), intermediate (CD51−/CD61−), and mesenchymal (CD106+/CD51+/CD61+) squamous cell carcinoma cells and subjected them to ATAC-seq [36]. Here, ITGAV is linked to squamous cell carcinoma.